AEVI Genomic Medicine (GNMX) was active in trading today. While the reason for the bump in activity is not immediately evident, it is possibly related to potential developments with the company’s pipeline research, including possible additional investment to keep the company sufficiently funded to complete its current research for one of its products. The company’s stock is down greatly since the beginning of the year due to a failure of a phase 2 study. Here’s a recap.
Written By: Howard Greenberg As everyday traders put their trading plans into action for 2026, penny stocks might not be on many of their radars. It’s totally understandable why penny stocks may not appeal to the more calculated seasoned traders. Their reputations for susceptibility to manipulation, extreme volatility, and low liquidity make them way too […]
Read Article
A high-profile policy debate has re-entered the financial spotlight surrounding credit card interest rate caps. Last week, President Donald Trump called for a temporary national cap on credit card interest rates. He proposed a maximum annual rate of 10% over a one-year period, starting January 20, 2026. President Trump’s proposal would aim to combat the […]
Read Article
Make no mistake…day trading options can be very profitable, but it can also be very risky. If you don’t know what you’re doing—you will get burned. When I first started day trading options, I learned that lesson the hard way quite a few times, but those experiences made me a better trader and coach. I’ll […]
Read Article
TeraWulf Inc. (WULF) has emerged as a standout Bitcoin mining stock—whose stock price is up over 136% in the last year. WULF’s explosive growth is driven by investor enthusiasm around the company’s strategic pivot and multi-billion-dollar high-performance computing (HPC) and AI data center deals. However, TeraWulf isn’t your ordinary Bitcoin miner. It’s among a group […]
Read Article
There’s quite a few stock market trends unfolding right now that are turning heads. If you ask some of the most successful traders out there, many will say that identifying and following these trends is a no brainer. Scott Bauer recently revealed two trending stock market sectors that are on his radar this month: He […]
Read Article
There’s been a huge chip stock rally in the market that’s turning a lot of heads. Here are just a few examples: Chip stocks were among the big names that dominated at CES this year in Las Vegas. In addition to the growing demand for chips, AI, and data storage, it’s understandable why there’s so […]
Read ArticleWe choose to let our members and students speak for themselves. We do not actively solicit testimonials, no compensation has been paid for any testimonial, and testimonials are not necessarily representative of the experience of all students. All monetary claims made in testimonials that you see depicted in our marketing material have been verified by Prosper Trading Academy and attested to by the members that have given them. Verified testimonials encompass “experience” reviews that highlight the personal experiences of working with our team and “performance” testimonials where we verify trading success of students who have enrolled in our programs.Given the broad reach of the internet, testimonials and reviews of our programs that we have not been able to verify can be found on various websites across the internet which are beyond our editorial control. While we do very much enjoy hearing positive things from our students and it is critical to our mission that everyone is satisfied with their journey with Prosper, we encourage you to take both verified and unverified testimonials for what they are.